ArticleLeukemia2022

Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.

Yuzhou Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.